Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
13F holders, Q1 2024 (March 31)2holders
$1.66avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Travere Therapeutics Inc. (tvtx 2.25 03/01/29) in their 13F filings. The largest holders were Nomura Holdings Inc. ($4.4M) and Jane Street Group, LLC ($2.1M).
- Company
- Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
- CUSIP
- 89422GAA5
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 2 holders
| Nomura Holdings Inc. | 0.04% | Add +17.0% | 564,387 | $4.4M |
| Jane Street Group, LLC | 0.00% | Reduce -8.3% | 3,333,000 | $2.1M |
"% of holder's portfolio" is TRAVERE THERAPEUTICS INC (TVTX 2.25 03/01/29)'s weight in each manager's 13F, not the share of Travere Therapeutics Inc. (tvtx 2.25 03/01/29) the manager owns.